Publication:
The prevalence of 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in central serous chorioretinopathy and its association with plasma PAI-1 levels.

Simple item page
dc.contributor.authorSogutlu, Sari
dc.contributor.authorYAZICI, A
dc.contributor.authorESER, B
dc.contributor.authorEROL, MK
dc.contributor.authorKILIC, A
dc.contributor.authorERMIS, SS
dc.contributor.authorKoytak, A
dc.contributor.authorAKŞIT, H
dc.contributor.authorYAKUT, T
dc.contributor.institutionauthorKOYTAK, İBRAHİM ARİF
dc.date.accessioned2019-10-05T14:44:20Z
dc.date.available2019-10-05T14:44:20Z
dc.date.issued2014-12-01
dc.identifier
dc.identifier.citationSogutlu S., YAZICI A., ESER B., EROL M., KILIC A., ERMIS S., Koytak A., AKŞIT H., YAKUT T., -The prevalence of 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in central serous chorioretinopathy and its association with plasma PAI-1 levels.-, Cutaneous and ocular toxicology, cilt.33, ss.270-4, 2014
dc.identifier.doi10.3109/15569527.2013.854372
dc.identifier.scopus84912100853
dc.identifier.urihttps://hdl.handle.net/20.500.12645/4616
dc.identifier.wosWOS:000345498400002
dc.language.isoen
dc.titleThe prevalence of 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in central serous chorioretinopathy and its association with plasma PAI-1 levels.
dc.typeArticle
dspace.entity.typePublication
local.article.journalnameUmut ve Yaşam
local.avesis.id7117d5b8-7ab9-4fe2-bd3b-ad6a1d229a8c
local.avesis.response4486
local.publication.isinternational1
relation.isAuthorOfPublicationad20e4da-e310-4188-9b32-8fb51734eb5f
relation.isAuthorOfPublication.latestForDiscoveryad20e4da-e310-4188-9b32-8fb51734eb5f
Files
Collections
Yayınlar - Eserler